II. Indications
- 
                          Postmenopause
                          - Any uterine bleeding
- Incidental, asymptomatic thickened endometrium on Ultrasound does NOT automatically reflex to biopsy- Consider Endometrial Cancer Risk Factors
 
 
- Premenopause- Age >45 years old with Abnormal Uterine Bleeding
- Age <45 years old with Abnormal Uterine Bleeding- Endometrial Cancer Risk Factors
- Persistent or heavy perimenopausal bleeding
- Refractory Anovulatory Dysfunctional Uterine Bleeding
- More than twelve months of Abnormal Uterine Bleeding
 
 
- Very high risk asymptomatic women- See Endometrial Cancer Risk Factors
- Morbid Obesity
- Unopposed Estrogen
- Chronic Anovulation
- Tamoxifen use
- Endometrial Hyperplasia surveillance
- Hereditary Non-polyposis Colorectal Cancer (Lynch Syndrome)- Lifetime risk of Endometrial Cancer 61%
- Screen with Endometrial Biopsy every 1-2 years starting at age 30-35 years
 
 
- 
                          Transvaginal Ultrasound with >4 mm endometrial thickness (endometrial stripe)- Endometrial thickness <=4 mm has a 99% Negative Predictive Value for Endometrial Cancer
- (2018) Obstet Gynecol 131(5):e124-9 [PubMed]
 
- Abnormal Pap Smear with Atypical Glandular Cells (AGUS)- Age over 35 years or Endometrial Cancer Risk Factors
 
III. Contraindications
- Absolute Contraindications- Pregnancy
- Acute Pelvic Inflammatory Disease
- Clotting disorder or Coagulopathy
- Acute cervical infection
- Acute vaginal infection
- Cervical Cancer
 
- Relative Contraindications or complicating factors- Morbid Obesity
- Uterine Descensus
- Severe cervical stenosis
 
IV. Efficacy
- 
                          Endometrial Cancer Diagnosis (As effective as Dilation and Curettage)- Test Sensitivity: 90 to 99% (91% in premenopausal women)
- Test Specificity: >97-100%
 
- 
                          Endometrial Hyperplasia Diagnosis- Test Sensitivity for Endometrial Hyperplasia 82%
- Test Specificity approaches 100%
- Can miss focal Endometrial Hyperplasia
 
- Insufficient sample (no glandular tissue) is common
- References
V. Equipment: General Materials
- Sterile gloves
- Povidone-Iodine solution (Betadine)
- Lidocaine gel 2% or 10% Lidocaine spray
- Sterile Gauze (4x4) for Betadine application
VI. Equipment: Sterile Uterine Pack (may use for IUD also)
- Sterile vaginal speculum
- Sterile Uterine sound
- Sterile scissors
- Sterile Ring forceps
- Sterile Cervical tenaculum
VII. Equipment: Biopsy Materials
- Endometrial suction catheter (e.g. Pipelle)
- Labeled formalin container
- Sterile cervical dilator available if needed
VIII. Technique
- Non-Sterile gloves for bimanual exam and speculum placement- Determine Uterine Size and position
- Insert speculum
- Change to sterile gloves
- Apply Topical Anesthetic (see below)
 
- Apply Topical Antiseptic solution (Povidone-Iodine)- Apply Povidone-Iodine to gauze or cotton balls
- Apply to Cervix and vagina with ring forceps
 
- Pain control
- Tenaculum use is optional
- Insert uterine sound to determine uterine depth- Normal depth: 6 to 8 cm
- Too shallow a depth may indicate the sound has not passed through the internal cervical os
 
- Obtain endometrial sample (consider 2-3 samples)- Insert suction catheter via cervical os to fundus
- Stabilize the catheter with one hand
- Withdraw internal piston to maximal point to apply suction within the catheter
- Move catheter tip in and out while twisting- Do not remove catheter from Uterus (suction lost)
- Twist catheter between 2 fingers to cover 360 degrees
- Make at least 4 in and out cycles per sample
 
- Withdraw catheter when filled with tissue and expel into specimen cup
 
- Store sample in formalin- Hold catheter over formalin container - with care not to touch formalin
- Reinsert internal piston to deposit sample in cup
 
- Remove the tenaculum- Bleeding at tenaculum site- Apply direct pressure
- Apply Silver Nitrate or Ferric Subsulfate (Monsel's Solution)
 
 
- Bleeding at tenaculum site
IX. Management: Stenotic cervical os
- 
                          Misoprostol (Cytotec) 200 mcg orally 6 hours before biopsy- Routine use, however, is not recommended for women without cervical stenosis
 
X. Management: Post-Procedure Instructions
XI. Interpretation
XII. References
- Apgar in Pfenninger (1994) Procedures 563-70
- Shelly (1997) Am Fam Physician 55(5): 1731-6 [PubMed]
- Williams (2020) Am Fam Physician 101(9): 551-6 [PubMed]
- Zuber (2001) Am Fam Physician 63(6): 1131-35 [PubMed]
